316 related articles for article (PubMed ID: 2302760)
1. Correlation between clastogenicity and promotion activity in liver carcinogenesis by N-hydroxy-2-acetylaminofluorene, N-hydroxy-4'-fluoro-4-acetylaminobiphenyl and N-hydroxy-4-acetylaminobiphenyl.
van de Poll ML; van der Hulst DA; Tates AD; Meerman JH
Carcinogenesis; 1990 Feb; 11(2):333-9. PubMed ID: 2302760
[TBL] [Abstract][Full Text] [Related]
2. Sulfation-dependent formation of N-acetylated and deacetylated DNA adducts of N-hydroxy-4-acetylaminobiphenyl in male rat liver in vivo and in isolated hepatocytes.
van de Poll ML; Venizelos V; Meerman JH
Carcinogenesis; 1990 Oct; 11(10):1775-81. PubMed ID: 1698568
[TBL] [Abstract][Full Text] [Related]
3. Formation and removal of DNA adducts in rat liver treated with N-hydroxy derivatives of 2-acetylaminofluorene, 4-acetylaminobiphenyl, and 2-acetylaminophenanthrene.
Gupta RC; Dighe NR
Carcinogenesis; 1984 Mar; 5(3):343-9. PubMed ID: 6705140
[TBL] [Abstract][Full Text] [Related]
4. N-acetylated and deacetylated 4'-fluoro-4-aminobiphenyl and 4-aminobiphenyl adducts differ in their ability to inhibit DNA replication of single-stranded M13 in vitro and of single-stranded phi X174 in Escherichia coli.
van de Poll ML; Lafleur MV; van Gog F; Vrieling H; Meerman JH
Carcinogenesis; 1992 May; 13(5):751-8. PubMed ID: 1586987
[TBL] [Abstract][Full Text] [Related]
5. 32P-postlabeling analysis of adducts generated by peroxidase-mediated binding of N-hydroxy-4-acetylaminobiphenyl to DNA.
Hatcher JF; Swaminathan S
Carcinogenesis; 1995 Sep; 16(9):2149-57. PubMed ID: 7554068
[TBL] [Abstract][Full Text] [Related]
6. The role of N-sulfation in the N-hydroxy-2-acetylaminofluorene-mediated outgrowth of diethylnitrosamine-initiated hepatocytes to gamma-glutamyltranspeptidase-positive foci in male rat liver.
Kroese ED; van de Poll ML; Mulder GJ; Meerman JH
Carcinogenesis; 1988 Nov; 9(11):1953-8. PubMed ID: 2902938
[TBL] [Abstract][Full Text] [Related]
7. The role of specific DNA adducts in the induction of micronuclei by N-hydroxy-2-acetylaminofluorene in rat liver in vivo.
van de Poll ML; van der Hulst DA; Tates AD; Mulder GJ; Meerman JH
Carcinogenesis; 1989 Apr; 10(4):717-22. PubMed ID: 2702720
[TBL] [Abstract][Full Text] [Related]
8. Association between DNA strand breaks and specific DNA adducts in murine hepatocytes following in vivo and in vitro exposure to N-hydroxy-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene.
Vu VT; Møller ME; Grantham PH; Wirth PJ; Thorgeirsson SS
Carcinogenesis; 1985 Jan; 6(1):45-52. PubMed ID: 4038475
[TBL] [Abstract][Full Text] [Related]
9. The role of sulfation in the metabolic activation of N-hydroxy-4'-fluoro-4-acetylaminobiphenyl.
van de Poll ML; Tijdens RB; Vondrácek P; Bruins AP; Meijer DK; Meerman JH
Carcinogenesis; 1989 Dec; 10(12):2285-91. PubMed ID: 2480190
[TBL] [Abstract][Full Text] [Related]
10. Sulfotransferase and deacetylase in normal and tumor-bearing liver of CD rats: autoradiographical studies with N-hydroxy-2-acetylaminofluorene and N-hydroxy-4-acetylaminobiphenyl in vitro and in vivo.
Shirai T; King CM
Carcinogenesis; 1982; 3(12):1385-91. PubMed ID: 6960974
[TBL] [Abstract][Full Text] [Related]
11. Initiation of hepatocarcinogenesis in infant male B6C3F1 mice by N-hydroxy-2-aminofluorene or N-hydroxy-2-acetylaminofluorene depends primarily on metabolism to N-sulfooxy-2-aminofluorene and formation of DNA-(deoxyguanosin-8-yl)-2-aminofluorene adducts.
Lai CC; Miller EC; Miller JA; Liem A
Carcinogenesis; 1987 Mar; 8(3):471-8. PubMed ID: 3815742
[TBL] [Abstract][Full Text] [Related]
12. The binding of N-hydroxy-2-acetylaminofluorene to DNA and repair of the adducts in primary rat hepatocyte cultures.
Howard PC; Casciano DA; Beland FA; Shaddock JG
Carcinogenesis; 1981; 2(2):97-102. PubMed ID: 6168407
[TBL] [Abstract][Full Text] [Related]
13. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice.
Lai CC; Miller JA; Miller EC; Liem A
Carcinogenesis; 1985 Jul; 6(7):1037-45. PubMed ID: 3860305
[TBL] [Abstract][Full Text] [Related]
14. Microsome-mediated transacetylation and binding of N-hydroxy-4-aminobiphenyl to nucleic acids by hepatic and bladder tissues from dog.
Hatcher JF; Swaminathan S
Carcinogenesis; 1992 Oct; 13(10):1705-11. PubMed ID: 1423829
[TBL] [Abstract][Full Text] [Related]
15. Human urinary bladder epithelial cells lacking wild-type p53 function are deficient in the repair of 4-aminobiphenyl-DNA adducts in genomic DNA.
Swaminathan S; Torino JL; Burger MS
Mutat Res; 2002 Jan; 499(1):103-17. PubMed ID: 11804609
[TBL] [Abstract][Full Text] [Related]
16. DNA damage in human transitional cell carcinoma cells after exposure to the proximate metabolite of the bladder carcinogen 4-aminobiphenyl.
Burger MS; Torino JL; Swaminathan S
Environ Mol Mutagen; 2001; 38(1):1-11. PubMed ID: 11473382
[TBL] [Abstract][Full Text] [Related]
17. Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol.
Meerman JH; Beland FA; Mulder GJ
Carcinogenesis; 1981; 2(5):413-6. PubMed ID: 7273322
[TBL] [Abstract][Full Text] [Related]
18. Metabolic activation of N-hydroxy-4-acetylaminobiphenyl by cultured human breast epithelial cell line MCF 10A.
Swaminathan S; Frederickson SM; Hatcher JF
Carcinogenesis; 1994 Apr; 15(4):611-7. PubMed ID: 8149470
[TBL] [Abstract][Full Text] [Related]
19. The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice.
Lai CC; Miller EC; Miller JA; Liem A
Carcinogenesis; 1988 Jul; 9(7):1295-302. PubMed ID: 3383346
[TBL] [Abstract][Full Text] [Related]
20. Induction of ornithine decarboxylase and augmentation of tyrosine aminotransferase activity by N-hydroxy-2-acetylaminofluorene and 2-acetylaminofluorene in rat liver. Influence of sex, retinylacetate, indomethacin, and pentachlorophenol.
Bisschop A; Bakker O; Meerman JH; van Wijk R; van der Heijden CA; Stavenuiter JF
Cancer Invest; 1984; 2(4):267-77. PubMed ID: 6147183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
